MedPath

A Long-Term Monitoring Study of the IMT-002 Patients

Not Applicable
Completed
Conditions
Macular Degeneration
Interventions
Device: IMT - Implantable Miniature Telescope
Registration Number
NCT00976235
Lead Sponsor
VisionCare, Inc.
Brief Summary

This is a 5-year study of patients implanted with the Implantable Miniature Telescope (IMT by Dr. Isaac Lipshitz) under Protocol IMT-002. All patients implanted with the telescope prosthesis who enrolled in the IMT-002 trial were asked to participate in this study to monitor long-term safety. Patients will undergo examinations at six-month intervals up to a total of 5 years following implantation.

Detailed Description

Every 6 months, manifest refraction, visual acuity, intraocular pressure, slit lamp examination, endothelial cell density, device failures, complications and adverse events will be assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
129
Inclusion Criteria
  • Patients must have participated in the IMT-002 trial.
  • Patients must be able to understand and comply with the requirements of the clinical study, and be able to abide by the requirements and restrictions of the study.
  • Patients must be able to provide voluntary informed consent, and must sign and be given a copy of the written Informed Consent form.
Exclusion Criteria
  • Patients who have not participated in the IMT-002 trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
IMTIMT - Implantable Miniature Telescope-
Primary Outcome Measures
NameTimeMethod
Long term safety (Intraocular pressure, Slit lamp, Endothelial Cell Density, Visual Acuity, Complications, Adverse Events and Device Failures)5 years from implantation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (28)

University of California at Irvine

🇺🇸

Irvine, California, United States

Wilmer Ophthalmological Institute

🇺🇸

Baltimore, Maryland, United States

Sarasota Retinal Institute

🇺🇸

Sarasota, Florida, United States

Emory Eye Center

🇺🇸

Atlanta, Georgia, United States

Paducah Retinal Center

🇺🇸

Paducah, Kentucky, United States

Wills Eye Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Retina Group of Washington

🇺🇸

Chevy Chase, Maryland, United States

Associated Retinal Consultants

🇺🇸

Royal Oak, Michigan, United States

Associated Eye Care

🇺🇸

Stillwater, Minnesota, United States

Doheny Retina Institute - University of Southern California

🇺🇸

Los Angeles, California, United States

Altos Eye Physician

🇺🇸

Los Altos, California, United States

Retina Centers P.C.

🇺🇸

Tucson, Arizona, United States

Manhattan Eye & Ear

🇺🇸

New York, New York, United States

Massachusetts Eye & Ear Infirmary

🇺🇸

Boston, Massachusetts, United States

Ophthalmic Consultants of Boston

🇺🇸

Boston, Massachusetts, United States

Kraft Eye Institute

🇺🇸

Chicago, Illinois, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

Dean A. McGee Eye Institute

🇺🇸

Oklahoma City, Oklahoma, United States

Vanderbilt University

🇺🇸

Nashville, Tennessee, United States

Medical Center Ophthalmology

🇺🇸

San Antonio, Texas, United States

Fine, Hoffman & Packer

🇺🇸

Eugene, Oregon, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

Discover Vision Centers

🇺🇸

Independence, Missouri, United States

Retina Associates of Cleveland

🇺🇸

Beachwood, Ohio, United States

Southeast Clinical Research

🇺🇸

Charlotte, North Carolina, United States

Duke University Eye Center

🇺🇸

Durham, North Carolina, United States

Vitreoretinal Foundation

🇺🇸

Memphis, Tennessee, United States

W.K. Kellogg Eye Center

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath